Archive · 20 Nov 2025
Narayana Hrudayalaya Stock Surges on Strong Q2 Results
Narayana Hrudayalaya's stock price has gone up a lot this year, especially after they released their good results for the summer.
The company says they don't know why their stock is doing so well, but some people think it might be because the company is doing well overseas.
The company is now one of the biggest hospital companies in India, and they have hospitals in other countries too.
However, some people are worried about how the company's business in the Cayman Islands and their recent purchase in the UK will do.
Narayana Hrudayalaya's stock has risen 57% in 2025, including a 14% increase in the past three trading sessions.
The rally follows the company's solid September quarter results, announced on November 14.
The company has no pending information or announcement that could explain the price/volume behavior of its shares.
Narayana Hrudayalaya is now the fourth-largest hospital stock by market capitalization.
The company's overseas presence, particularly in the Cayman Islands, sets it apart from its larger peers.
- Who
- Narayana Hrudayalaya Ltd
- What
- Experienced a significant stock price increase
- When
- So far in 2025, with a 14% increase in the past three trading sessions
- Where
- Indian stock market
- Why
- Due to strong Q2 results and overseas presence
Optimistic Investors
Cautious Investors
Cayman Islands Operations
Optimistic Investors
Potential for growth and high Ebitda margin
Cautious Investors
Complex business model and losses in health insurance business
UK Acquisition
Optimistic Investors
Reasonable acquisition price at 12x EV/EBITDA
Cautious Investors
Muted stock reaction to acquisition and potential integration challenges
Indian Operations
Optimistic Investors
Strong Ebitda margin similar to Apollo's hospital segment
Cautious Investors
Lower Ebitda per patient compared to Apollo
- Market Capitalization Rank
- Fourth-largest
- Overseas Revenue Share
- Over 25% in Q2 of FY26
- Acquisition
- Practice Plus Group Hospitals in the UK for GBP 183 million
- Funding for Acquisition
- GBP 40 million equity from Cayman operations and debt
- P/E Ratio
- 35x based on FY27, lower than larger peers